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Recent guidelines from the National Institute of Health and Care Excellence (NICE) and the UK National
Health Service (NHS) have stipulated that intraoperative ﬂow monitoring should be used in high-risk
patients undergoing major surgery to improve outcomes and reduce costs. Depth of anaesthesia
monitoring is also recommended for patients where excessive anaesthetic depth is poorly tolerated,
along with cerebral oximetry in patients with proximal femoral fractures. The aims of this descriptive
case series were to evaluate the impact of a multimodal intraoperative strategy and its effect on mortality
and amputation rate for patients with critical leg ischaemia.
In an observational case series, 120 elderly patients undergoing major infra-inguinal bypass between
2007 and 2012 were included in this retrospective analysis of prospectively collected data. Nominal
cardiac output (nCO, LiDCOrapid, LiDCO Ltd, UK), bispectral index to monitor depth of anaesthesia (BIS,
Covidien, USA) and cerebral oxygenation, rSO2 (Invos, Covidien, USA) readings were obtained before
induction of general anaesthesia and throughout surgery.
30 day, 1-year mortality and amputation rates were analysed. Demographics and physiological pa-
rameters including correlation with V-POSSUM, age, gender and other co-morbidities were statistically
analysed.
Thirty-day mortality rate was 0.8% (n ¼ 1). V-POSSUM scoring indicated a predicted mortality of 9%.
Amputation rate was less than 2% at one year. Only 8% of patients (10 of 120) were admitted to a high
dependency unit (HDU) postoperatively.
30-day mortality in our case series was lower than predicted by V-POSSUM scoring. Use of multimodal
intraoperative monitoring with the speciﬁc aim of limiting build-up of oxygen debt should be subjected
to a randomised controlled study to assess the reproducibility of these results.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
High-risk surgical procedures represent about 12.5% of surgery
carried out in the UK but contribute to 84% of deaths.1 Elderly pa-
tients constitute an increasingly large proportion of the high-risk
surgical group and undergo surgery four times more often than
younger patients.2 The 30-day mortality is higher in the elderly and
has recently been quoted as 5%e10%.3 A recent study from the USA
in a similar group of high-risk vascular surgical patients to those
reported here had an overall 30-day mortality of 5.1%.4 The mor-
tality in similar patients in the UK is probably higher.5 This general
high surgical morbidity and mortality in the UK has led to recentdr-green.co.uk (D. Green),
k (H. Rashid).
ciates Ltd. Published by Elsevier Ltguidance from the NHS and NICE which has mandated the use of
ﬂow monitoring (initially evaluating the Oesophageal Doppler6
(ODM) and subsequently including all ﬂow monitors7) in high-
risk patients in an attempt to improve patient outcomes and
thereby produce net savings estimated at £400m per annum.7
Following NICE evaluation,8 further guidance from the NHS has
also suggested the use of depth of anaesthesia monitoring in pa-
tients at risk of the adverse effects of excessively deep anaesthesia
including the elderly and those with poor cardiovascular function.9
In 2012 the Association of Anaesthetists of Great Britain and Ireland
have added cerebral oximetry, alongside ﬂow and depth of anaes-
thesia, to the list of additional monitors for use in another group of
very high risk patients, those with proximal femoral fractures.10
Recent studies using the ODM11 on its own have failed to substan-
tiate evidence from previous trials of beneﬁt or superiority to re-
gimes aiming at simply minimising ﬂuid input.12 This suggests that
a more complex strategy may be needed to improve outcome ind. All rights reserved.
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minimise cardiovascular depression and cerebral oxygenation to
assess the adequacy of tissue perfusion.13
Many scoring systems that predict patients’ morbidity and
mortality have been developed over the years. The most commonly
used one in vascular surgery is the Vascular-Physiological and
Operative Severity Score for the enUmeration of Mortality and
Morbidity (V-POSSUM) which is a risk-adjusted scoring system and
potentially useful in predicting 30-day mortality in high-risk pa-
tients undergoing vascular surgery.14
Multimodal monitoring has been the subject of recent re-
views.13,15 In brief, the LiDCOrapid (LiDCO Ltd, UK)16 was used for
haemodynamic monitoring and an attempt was made to maintain
nominal cardiac output (nCO) and oxygen delivery (nDO2)
throughout surgery to within 10% of the pre-induction value in
these elective patients to minimise build-up of oxygen debt, a
major predictor of morbidity and mortality.17 Depth of anaesthesia
or more correctly degree of cortical suppressionwas assessed by BIS
(Covidien, USA) and the value during anaesthesia maintained at the
recommended range of 40e60.18 This strategy has recently been
shown to reduce the incidence of delirium and cognitive dysfunc-
tion in elderly patients,19,20 signiﬁcant predictors of poor
outcome.21 Cerebral oxygen saturation (rSO2) can be monitored by
the use of near infrared technology (NIRS), a technology which has
been available clinically for around 15 years.22 Cerebral oximetry
(Invos, Covidien, USA) provides an index of brain (and overall tis-
sue) oxygenation.23 A baseline value of rSO2, prior to induction of
anaesthesia, is essential to provide an index fromwhich tomeasure
cumulative desaturation.24The normal rSO2 in a ﬁt patient may be
around 60e70%, however, values as low as 35% are seen in elderly
patients presenting for cardiac surgery and is probably associated
with poor outcome.25
There is still considerable debate about the cost/beneﬁt that
such a combined monitoring strategy would involve or indeed
whether it would be possible to maintain ﬂow, depth of anaes-
thesia26 and cerebral oxygenation in the recommended range in
very high risk elderly patients. Multimodal monitoring using ﬂow,
depth of anaesthesia and cerebral oxygen monitoring with a
deﬁned strategy for intraoperative management has been utilised
for the last 5 years in our unit for high risk patients undergoing
complex major infra-inguinal bypass surgery for critical leg
ischaemia (CLI).
To our knowledge the impact of intraoperative multimodal
monitoring with a pre-emptive strategy of reducing build-up of
oxygen debt on reducing morbidity and mortality of vascular pa-
tients has not been reported.
The aim of this study was to evaluate this strategy and the
possible effect on outcome in terms of mortality and major
amputation rate.
2. Methods
This is a retrospective analysis of prospectively collected data of
a case series of 120 patients with critical lower limb ischaemia (CLI)
who underwent complex major infra-inguinal bypass between
October 2007 and January 2012. Local ethical committee approval
was sought but was not deemed necessary as the procedures car-
ried out were normal practice in this unit. Consecutive patients
whowere treated by the same surgical and anaesthetic teams were
included in the study.
Data were collected from electronic hospital and anaesthesia
records. 1-year follow-ups were conducted by telephone in-
terviews. The 30-day and 1-year mortality rates were calculated.
The analysed variables were age, gender, anaemia, diabetes melli-
tus (DM), ischaemic heart disease/myocardial infarction (IHD/MI),chronic obstructive pulmonary disease (COPD), cerebrovascular
disease (CVD), and renal dysfunction/failure (RF). Anaemia was
deﬁned as haemoglobin levels lower than 130 g l1 in men and
lower than 115 g l1 in women and RF was deﬁned as estimated
glomerular ﬁltration rate (eGFR) of less than 60 ml min1. This
value was chosen as a recent meta analysis has shown an eGFR of
less than 60 to be a strong predictor of all cause mortality in
vascular surgery.27 This data also included the type of bypass ac-
cording to the anatomical position of the distal anastomosis.
Femoro-popliteal bypass was deﬁned as having the distal anasto-
mosis to the popliteal artery and femoro-distal bypass was deﬁned
as having the distal anastomosis to the crural or pedal arteries.
2.1. Intraoperative management
In addition to routine monitoring, baseline BIS and rSO2 read-
ings were obtained in the majority of patients pre-induction of
anaesthesia. A radial artery line was inserted under local anaes-
thesia and connected to a LIDCOrapid, a pulse power analysis car-
diac output monitor.16 This enabled pre-induction nominal
(“calibrated” using a nomogram utilising age, weight and height)
cardiac output (nCO), stroke volume (nSV) and nominal oxygen
delivery (nDO2) data to be obtained continuously.
Anaesthesia was induced using target-controlled intravenous
anaesthesia (TCI) using remifentanil (administered until a 2e
3 ng ml1) predicted effect site concentration, Ceff, was achieved
and 2% propofol administered to maintain depth of anaesthesia in
the range of BIS values between 40 and 60 (see Table 3). Haemo-
dynamic variables, as above, were continuously monitored via
LIDCOrapid, enabling appropriate use of vasopressor drugs or
ﬂuids28 to maintain the baseline nDO2 within 10% of the pre-
induction value, minimising the build-up of signiﬁcant oxygen
debt. rSO2 was maintained to within 10% of baseline as previously
described.20 All patients received antibiotic prophylaxis and core
body temperature in the 36 to 37 C range was maintained with
forced air and under patient warming.
nCO and other haemodynamic parameters were collected at
5 s intervals in the LiDCOrapid, BIS and rSO2 readings were obtained
from the respective monitors at 30 s intervals.
Statistical analysis was performed on age, gender, diabetes,
renal impairment or failure (RF), ischaemic heart disease and
myocardial infarction (IHD/MI), chronic obstructive pulmonary
disease (COPD) and cerebrovascular disease (CVD). Correlation was
considered signiﬁcant when the p value was <0.05.
Assessment of the ability of this strategy to maintain nDO2 was
assessed by analysing:
1. The ratio of average nCO obtained during surgery from the
LiDCOrapid and the pre-induction value. From this a prediction
could be made of likely oxygen debt during surgery.
2. The average value of BIS obtained during the procedure. An
attempt was made to keep this in the 40 to 60 range.18
3. Variation in the amount of propofol needed in mg kg1 h1 to
maintain BIS in the normal range.
4. The ratio of average rSO2 obtained during the procedure and its
relation to the starting value. Maintenance of intraoperative
rSO2 at similar (or higher) value to pre-induction would suggest
that build-up of oxygen debt was minimal2.2. Statistical methods
Univariate and multivariate analysis were performed on age,
gender, diabetes mellitus (DM), renal impairment (RF), anaemia,
ischaemic heart disease and history of myocardial infarction (IHD/),
Table 2
Multivariate analysis of risk factors for 1 year mortality. For abbreviations, see text.
Parameter p Value Odd ratio/(95% CI)
Age 0.013 1.087/(1.018e1.161)
Gender 0.757 0.804/(0.201e3.215)
DM 0.471 1.537/(0.477e4.954)
IHD/MI 0.193 0.249/(0.031e2.018)
CVD 0.018 4.061/(1.269e12.991)
RF 0.056 3.176/(0.973e10.370)
Anaemia 0.294 0.486/(0.126e1.870)
COPD 0.925 0.901/(0.102e7.935)
Table 3
Operative details and postoperative location.
Parameter Value
(mean)
Range or %
Operation duration (h) 4.4 2.8e7.45
Monitoring and iv access (nos)
Radial arterial line 120 100%
Central line 9 6%
Cerebral oximeter (Invos, rSO2) 100 83%
BIS 120 100%
Surgical procedure
Femoro-distal bypass 79 66%
other femoral bypass 41 38%
Anaesthesia
Propofol (mg kg h1) 4.4 2.1e8.2
Remifentanil (mg kg min1) 0.07 0.04e0.14
Controlled ventilation 120 100%
Intubation: laryngeal mask airway (nos) 96 80%
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disease (CVD). Correlation was considered signiﬁcant when the p
value was <0.05.
Receiver Operator Characteristic (ROC) analysis was applied to
rSO2 and its correlationwith age, gender and the above selected co-
morbidities. using Medcalc (Belgium).
3. Results
Data from 120 patients (median age; 72 years, range 45e95, 97
were male) were analysed. Patient characteristics are summarised
in Table 1. Most of the bypasses were distal (n ¼ 79, 66%) followed
by femoro-popliteal (n ¼ 29, 24%). Duration of surgery ranged be-
tween 2.8 and 7.45 h (median of 4.4 h). Intraoperative details and
perioperative management are summarised in Table 3.
The within 30-day mortality rate was 0.8% (n ¼ 1) and 1-year
mortality was 12% (n ¼ 14). V-Possum scoring predicted a 30-day
mortality rate of 9%. Most of deaths were not documented to be
related to a speciﬁc cause (8 patients). Two deaths occurred as a
result of cardiac complications, and 2 secondary to severe sepsis
and cancer. Acute renal failure and multi-organ failure were each
responsible for one death. There was no difference in mortality in
terms of bypass type, 10 distal bypass and 4 femoro-popliteal out of
79 (12.5%) and 29 (14%) respectively, died within 1 year (p value:
1.0). Similarly, the length of surgery did not correlate to the mor-
tality rate (6 deaths <4 h), and (8 deaths >4 h) (p value 0.563).
Only age and CVDwere signiﬁcant predictors of 1-yearmortality
with p values ¼ 0.013 and 0.018, and odd ratios of 1.87 and 4.061
respectively (Table 2).
3.1. Effectiveness of intraoperative monitoring strategy
3.1.1. Nominal cardiac output and oxygen delivery
The overall ratio of nCO during the procedure compared with
that of the pre-induction value was 87% (based on complete data in
109 patients, IQR 75e97).
3.1.2. BIS
Average BIS during anaesthesia maintenance was 45 (range
34e55).
3.1.3. rSO2
Themean starting rSO2 in100patientswas54 (range; 31e80). The
ROC for 1 yearmortality showed that starting rSO2 had some value inTable 1
Patient demographics, investigations and co-morbidities. For abbreviations see text.
Parameter Value/No. Range or %
Age (years, mean and range) 72 45e95
Male 97 81%
Female 23 19%
Weight (kg, mean and range) 78 37e125
Diabetes mellitus 80 67%
Ischaemic heart disease/infarction 37 31%
Hypertension 56 47%
Cerebrovascular disease 28 23%
Renal impairment 45 37%
Anaemia 38 32%
Chronic obstructive pulmonary disease 10 8%
ASA (mean and range) 3 2e4
V-POSSUM predicted 30 day mortality
(range for all patients)
9% 1e45
Actual 30 day mortality 0.80%
Hb (g$l1, mean and range) 118 (79e170)
Estimated. creatinine clearance (eCC) ml
min1 (mean and range)
63 (8e190)predicting one year survival as the area under the curve (AUC) was
0.61 (95% conﬁdence interval of 0.533e0.744) (p< 0.05). No one year
mortality occurred inpatientswhohad a starting rSO2 of greater than
62. The ratio of rSO2 during anaesthesia maintenance to the pre-
induction baseline was 112% (range 87e163). Low starting rSO2 had
a statistically signiﬁcant correlation with anaemia and diabetes
mellitus (Fig. 1) AOC: 0.75 and AUC: 0.7; p ¼ 0.0001 and 0.0002
respectively. No statistical correlation was seen between starting
rSO2 and previous IHD/MI, pre-induction nCO, RF or CVD. Similarly,
therewas no correlation between the starting rSO2 and age (p¼ 0.17).
3.1.4. Outcome
The major amputation rate at 1 year was 2% with 0% at one year
in diabetics having distal bypass.
Nine patients (8%) had a central line inserted pre-induction due
to lack of peripheral venous access. Postoperatively 110 (92%)Intubation: endotracheal tube (nos) 24 20%
Cisatracurium (neuromuscular blocker) 120 100%
BIS levels (mean and range) 45 34e55
Fluid input
Crystalloid Hartmann’s (ml) 567 100e1800
Crystalloid Glucose (0.4%) NaCl (0.18%) (ml) 898 100e2000
Colloid (ml) 880 100e3000
Fluid in ml kg1 h1 (excluding blood) 4.9 1.2e12.3
Blood (ml) 224 0e2700
Fluid output
Urine output (ml.) 904 50e2400
Blood (ml.) 430 0e3000
Inotrope/vasoactive drug use
Phenylephrine mg. (63 patients) 4.3 1e13
Ephedrine mg (73 patients) 13 3e55
Intraoperative haemodynamics
Mean nCO lpm, as % of pre-induction value 87 43e130
Mean rSO2 as % of pre-induction value (100 pts) 112 87e163
Postoperative location (no of pts)
High dependency unit 10 8%
General ward following recovery ward 110 92%
Abbreviations: rSO2 regional oxygen saturation % (Invos, Covidien, USA); BIS (bis-
pectral index, Covidien, USA); nCO nominal cardiac output (LiDCOrapid, LiDCO
PLC, UK).
Fig. 1. Low starting rSO2 had a statistically signiﬁcant correlation with the presence of
diabetes mellitus. AUC: 0.7; p ¼ 0.0002.
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(8%) were admitted electively to the high dependency unit (HDU).
(See Table 3).
4. Discussion
The economic and personal cost of morbidity and mortality
from high risk surgery has led to the recommendation for advanced
perioperative monitoring in an attempt to reduce these costs and
complications, especially the use of ﬂow and depth of anaesthesia
monitoring during surgery.6,7 Although recent meta-analyses had
suggested a reduction in mortality with the addition of ﬂow
monitoring as a pre-emptive strategy,29,30 this was not conﬁrmed
in a recent Cochrane review.31 Maintaining pre-induction levels of
nCO and nDO2 during elective, high risk surgery, by using the pa-
tient as their own control, may be a better strategy than trying to
achieve unrealistic and arbitrary population based targets such as a
DO2 of 600 ml m2 This oxygen delivery target would require a CO
of around 10 l min1 in a patient with a Hb of 80 g l1. Perhaps
achievable in a 30 year old but not easily obtainable and potentially
dangerous in an 80 year old! In addition, a high dependency unit
(HDU) with invasive monitoring, signiﬁcant ﬂuid input and the
addition of inotropes would be needed.
Studies have also suggested that patients undergoing high-risk
surgery beneﬁt from preoperative32 or postoperative33 optimisa-
tion to improve outcomes. Such strategies are resource intensive
and may not be needed as long as DO2 is maintained intra-
operatively. From the physiological point of view, this makes sense
as the heart is the servant of the circulation and not the other way
round. Attempting to increase DO2 by driving the heart to unsus-
tainable levels of CO using a stroke volume optimisation/max-
imisation strategy will not necessarily mean that cells and tissues
are better oxygenated and may be deleterious in the elderly.34
The role of ‘combined’ advanced intraoperative monitoring to
reduce oxygen debt and improve outcomes in the elderly patient
has been emphasised,13,15 alongside the urgent need for large
prospective randomised controlled trials in the perioperativeperiod.35 Multimodal monitoring in the high risk elderly patient
has also been stressed in recently published guidelines for man-
aging proximal femoral fractures in the UK and includes using
depth of anaesthesia, ﬂow monitoring together with cerebral ox-
imetry.10 The rationale for this combined approach has been the
subject of a recent review.15
What is the current level of evidence that a combination of these
monitoring technologies might be beneﬁcial15? This has emerged
from studies looking at depth of anaesthesia, cerebral oxygenation
and haemodynamics on outcome.
4.1. Depth of anaesthesia monitoring and morbidity and mortality
Although there is conﬂicting evidence that BIS consistently
below 45 on its own is associated with poor outcome,26,36,37 this is
probably only the case when low BIS is combined with low MAP
<75 mmHg and increased “anaesthetic sensitivity” (i.e. low mini-
mal alveolar concentration- MAC of less than 0.7). This so-called
‘triple low’ was associated with an estimated four-fold increase in
30 daymortality.38The average BIS value was maintained here at 45
and the study found no evidence that BIS values are inherently
lower in this group of high risk patients as suggested by other
studies.26 However, a 4-fold variation in propofol requirements
(2.1e8.2 mg kg1 h1) was needed to maintain BIS in the 40 to 60
range (Table 3).
4.2. Cerebral and tissue oxygenation
Reducing the build-up of oxygen debt and maintaining tissue
oxygenation are key elements of this strategy. “Measuring and
obtaining adequate tissue oxygenation may prevent postoperative
complications and may thus be cost effective”.23
4.3. Calculation of predicted oxygen debt
In the original Shoemaker study this was calculated as the dif-
ference between the oxygen consumption (VO2) obtained pre-
induction and the VO2 obtained during the operative procedure
(using a pulmonary artery catheter and thermo-dilution cardiac
output).17 He also assumed that the VO2 during surgery would fall
by about 15% to compensate for reduced oxygen requirement from
the combined effects of anaesthesia and temperature change. So, if
the VO2 were 250 ml min1 pre-induction then about 210 ml
would be expected on average during the procedure and, if ach-
ieved, would not result in a build-up of oxygen debt. If VO2 was less
than this it would result in accumulation of oxygen debt. If the
actual VO2 were 110 ml during surgery then oxygen debt would be
accumulating at the rate of 100 ml min1 or 6 l h1. For a patient
with a body surface area of 2 m2 this would amount to 3 l m2 h1.
The threshold for the potential of non-survival in his series at
the end of surgery was around 10 l m2 overall, which could
occur over a 3-h procedure and put the patient at risk. In general,
intraoperative VO2 was closely related to CO and DO2 and in non-
survivors it had to fall by at least 15e20% during surgery before
signiﬁcant oxygen debt accumulated. Thus, in this series, although
VO2 was not measured directly, maintaining intraoperative nDO2 at
about 80e90% of pre-induction level may be comparable. In addi-
tion, if rSO2 was maintained at or above the pre-induction level it
would suggest that this was an appropriate strategy.
Current intraoperative management has placed less emphasis
on preventing the build-up of O2 debt intraoperatively and more
on playing ‘catch up’ by repaying presumed intraoperative oxygen
debt in the immediate postoperative period. A pre-emptive hae-
modynamic strategy using LiDCO and BIS, demonstrates that
intraoperative nCO and nDO2 can be maintained at around 90% of
D. Green et al. / International Journal of Surgery 12 (2014) 231e236 235
ORIGINAL RESEARCHpre-induction values even in high risk patients. Maintenance of
cerebral rSO2 suggests that tissue oxygenation was adequate. This
strategy also reduced dramatically the requirement for post-
operative high dependency management with only 8% of patients
requiring admission to HDU.
4.4. Is infra-inguinal bypass surgery high risk?
Infra-inguinal bypass surgery carries a very high risk of post-
operative morbidity and mortality. Recent studies showed that
infra-inguinal bypass has a 10e21% risk of major amputation and
30-day and 1-year mortality rates of 5e8% and 18e20%4,5 respec-
tively. Indeed, after major amputation alone, the 30 day mortality
may approach 10%.39 Could multimodal monitoring reduce this
high level of mortality and morbidity? Many of the patients pre-
sented here were refused surgery elsewhere because of this high
morbidity and mortality and may be offered angioplasty instead as
a “safer alternative”. The long term impact of this strategy has been
the subject of a recent trial which suggests that although angio-
plasty carries a lower short term risk it’s beneﬁcial effects are
reduced after one year or so.40
4.5. Outcome: does multimodal monitoring make a difference to
outcome?
What about the impact of the multimodal monitoring strategy
on mortality? V-POSSUM scoring system, like any other prediction
system, uses multiple variables to predict 30-days mortality after
vascular surgery.14 Our low within 30-day mortality rate (0.8%)
compared with 9% predicted suggests that we can improve
outcome in this group of elderly patients and this proposition
should be addressed by a large, randomised controlled trial.35
As for morbidity, the major amputation rate was 2% with 0% at
one year in diabetics. Within 30-day and 1-year mortality was 0.8%
and 13.7% respectively. With morbidity and mortality this low,
more patients could possibly be offered a deﬁnitive bypass rather
than being subjected to preliminary angioplasty which might also
prejudice the success of a future bypass if needed.5
There are limitations to this study. Although the patients were
not randomised to receive multimodal monitoring and thus are
subject to bias, this was a consecutive series of patients operated
upon by the same surgical and anaesthetic team. No patients were
excluded from analysis. In addition, many of the patients accepted
for bypass operation had been refused surgery elsewhere due to the
high-predicted mortality from the V-POSSUM score.
Multimodal monitoring is costly but net savings in the UK
looking speciﬁcally at ﬂow monitoring are estimated to be around
£400 m per annum. The reduction in requirement for central
venous catheterisation, postoperative admission to HDU and good
patient outcomes with low morbidity and mortality suggests that
multimodal monitoring should be cost effective. However, it is
essential that propositions such as this be subjected to a large,
randomised controlled trial before widespread implementation.35
5. Conclusion
Multimodal monitoring combining ﬂow with depth of anaes-
thesia and cerebral oxygenation appeared to reduce morbidity and
mortality as compared to other reported studies in this group of
high-risk, elderly patients undergoing major infra-inguinal bypass
surgery for critical leg ischaemia. Intraoperative maintenance of
cardiac output, oxygen delivery and depth of anaesthesia to mini-
mise oxygen debt may have contributed to the low morbidity and
30-day mortality and should be subjected to a randomised
controlled trial.Ethical approval
Ethical approval was not deemed necessary, as advised by the
Research and development department.
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